Ignite Creation Date:
2025-12-24 @ 10:07 PM
Ignite Modification Date:
2026-01-02 @ 1:18 AM
Study NCT ID:
NCT05119335
Status:
TERMINATED
Last Update Posted:
2025-11-12
First Post:
2021-10-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma
Sponsor:
NiKang Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-10-26
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-09-30
Completion Date Type:
ACTUAL
First Submit Date:
2021-10-14
First Submit QC Date:
None
Study First Post Date:
2021-11-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-10
Last Update Post Date:
2025-11-12
Last Update Post Date Type:
ESTIMATED